Abstract
BackgroundIn general, the concomitant use of methotrexate (MTX) and biologic disease-modifying antirheumatic drugs (DMARDS) plays an important role in treatment for bio-naïve patients with rheumatoid arthritis (RA). However, it remains...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
